HN user

byzantinegene

214 karma
Posts0
Comments121
View on HN
No posts found.

the reselling of fixed price plans by resellers are causing american labs to lose alot of money and that's why they're trying really hard to stamp it down.

when they IPO, their financials will be under scrutiny, and exponential revenue growth would be required to justify their trillion dollar valuation

churning out assembly code would cost far more in tokens, wouldn't make financial sense for the improved performance which doens't matter that much for most use cases.

it makes financial sense at current subscription prices, but this might not hold true when they have to raise prices eventually